New Boxed Warning for Osteoporosis Drug

被引：0

作者：

Aschenbrenner, Diane S. ^{[1
,2
]}

机构：

[1] Maryland Univ, Fac Notre Dame, College Pk, MD USA

[2] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21218 USA

来源：

AMERICAN JOURNAL OF NURSING | 2024年 / 124卷 / 06期

关键词：

D O I：

10.1097/01.NAJ.0001023940.55090.83

中图分类号：

R47 [护理学];

学科分类号：

1011 ;

摘要：

A boxed warning has been added to the labeling of denosumab (Prolia) highlighting an increased risk of severe hypocalcemia in patients with advanced chronic kidney disease.Nurses and NPs should confirm that hypocalcemia is corrected prior to patients starting therapy. Patients should be educated on the need to have their calcium levels checked regularly while taking denosumab, as well as on the signs and symptoms of hypocalcemia.

引用

页码：19 / 19

页数：1